John E. Dick, PhD, FRS, FRsC, FAACR
AACR Award for Outstanding Achievement in Blood Cancer Research

John E. Dick, PhD, FRS, FRsC, FAACR

Senior Scientist and Canada Research Chair in Stem Cell Biology
Princess Margaret Cancer Centre, University Health Network
Professor, Department of Molecular Genetics
University of Toronto
Toronto, Ontario, Canada

For pioneering and championing the application of genomics to cancer research, diagnosis, drug development, and tFor his groundbreaking discovery of leukemic stem cells and for developing the first hematopoietic xenograft assay using human hematopoietic cells transplanted into immune-compromised mice, a technique that has become the gold standard hematopoietic stem cell assay. His discovery of a leukemia stemness gene signature has since been used to predict survival rates and response to treatment and lays the groundwork for identifying actionable targets for drug development.

The AACR established this award to recognize an individual for meritorious achievements and contributions to basic, translational, or clinical research related to blood cancer or associated disorders such as myelodysplastic syndrome or myeloproliferative neoplasms. Funding for the inagural award is being provided by an unrestricted educational grant from Pharmacyclics, an AbbVie Company and Janssen Biotech, Inc. To learn more, please visit the press release.

View Dr. Dick’s Fellows of the AACR Academy page.

View Past Recipients